Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age

Placenta

Volumn 23, Issue 5, 2002, Pages 447-450

  Rakheja, D ^a   Bennett, M J ^a,b   Foster, B M ^c   Domiati Saad, R ^a   Rogers, B B ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GESTATIONAL AGE; HELLP SYNDROME; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LIVER INJURY; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; CHORION VILLUS; CLASSIFICATION; ENZYMOLOGY; FEMALE; METABOLISM; OXIDATION REDUCTION REACTION; PREGNANCY;

3-HYDROXYACYL COA DEHYDROGENASES; ADULT; CHORIONIC VILLI; FATTY ACIDS; FEMALE; GESTATIONAL AGE; HUMANS; OXIDATION-REDUCTION; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0036581549     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0808     Document Type: Article

References (33)

1. Bennett MJ, Weinberger MJ, Kobori JA, Rinaldo P & Burlina AB (1996) Mitochondrial short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: a new defect of fatty acid oxidation. Pediatr Res, 39(1), 185-188.
2. Benirschke K & Kaufman P (2000) Normative Values and Tables. In Pathology of the Human Placenta (Eds) Benirschke K & Kaufman P, p. 923. New York: Springer-Verlag.
3. Hennig B & Chow CK (1988) Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med, 4(2), 99-106.
4. Henriksen T (2000) The role of lipid oxidation and oxidative lipid derivatives in the development of preeclampsia. Semin Perinatal, 24(1), 29-32.
5. Herrmann U Jr, Degiampietro P, Metzger E, Bachmann C & Peheim E (1985) Activities in the placenta and fetal membranes of enzymes involved in energy metabolism. Arch Gynecol, 236(4), 249-254.
6. Herrera E & Amusquivar E (2000) Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev, 16(3), 202-210.
7. Hicks P, Bennett MJ, Squires J & Ramilo O (1995) Heterozygosity for long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency and deterioration in liver function in a newborn infant infected with human immunodeficiency virus. J Pediatr, 127(4), 599-602.
8. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF & Strauss AW (1999) A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med, 340(22), 1723-1731.
9. IJlst L, Ruiter JP, Hoovers JM, Jakobs ME & Wanders RJ (1996) Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest, 98(4), 1028-1033.
10. IJlst L, Wanders RJA, Ushikubo S, Kamijo T & Hashimoto T (1994) Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta, 1215, 347-350.
11. Innes AM, Seargeant LE, Balachandra K, Roe CR, Wanders RJ, Ruiter JP, Casiro O, Grewar DA & Greenberg CR (2000) Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res, 47(1), 43-45.
12. Isaacs JD Jr, Sims HF, Powell CK, Bennett MJ, Hale DE, Treem WR & Strauss AW (1996) Maternal acute fatty liver of pregnancy associated with fetal trifunctional protein deficiency: molecular characterization of a novel maternal mutant allele. Pediatr Res, 40(3), 393-398.
13. Madazli R, Benian A, Gumustas K, Uzun H, Ocak V & Aksu F (1999) Lipid peroxidation and antioxidants in preeclampsia. Eur J Obstet Gynecol Reprod Biol, 85(2), 205-208.
14. Matern D, Hart P, Murtha AP, Vockley J, Gregersen N, Millington DS & Treem WR (2001a) Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr, 138(4), 585-588.
15. Matern D, Shehata BM, Shekhawat P, Strauss AW, Bennett MJ & Rinaldo P (2001b) Placental floor infarct complicating the pregnancy of a fetus with long chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Mol Genet Metab, 72(3), 265-268, doi:10.1006/mgme.2000.3135.
16. Mutlu-Turkoglu U, Ademoglu E, Ibrahimoglu L, Aykac-Toker G & Uysal M (1998) Imbalance between lipid peroxidation and antioxidant status in pre-eclampsia. Gynecol Obstet Invest, 46(1), 37-40.
17. Nelson J, Lewis B & Walters B (2000) The HELLP syndrome associated with fetal medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis, 23(5), 518-519.
18. Pollitt RJ (1995) Disorders of mitochondrial long-chain fatty acid oxidation. J Inherit Metab Dis, 18(4), 473-490.
19. Poranen AK, Ekblad U, Uotila P & Ahotupa M (1996) Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta, 17(7), 401-405.
20. Prip-Buus C, Pegorier JP, Duee PH, Kohl C & Girard J (1990) Evidence that the sensitivity of carnitine palmitoyl transferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes. Biochem J, 269(2), 409-415.
21. Redman CW & Sargent IL (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta, 21(7), 597-602, doi:10.1053/plac.2000.0560.
22. Roberts JM & Hubel CA (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet, 354(9181), 788-789.
23. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA & McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol, 161(5), 1200-1204.
24. Saggerson ED & Carpenter CA (1982) Regulation of hepatic carnitine palmitoyl transferase activity during the fetal-neonatal transition. FEBS Lett, 150(1), 177-180.
25. Schoeman MN, Batey RG & Wilcken B (1991) Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. Gastroenterology, 100(2), 544-548.
26. Shekhawat PS, Bennett MJ, Rakheja D & Strauss AW (2001) Fatty acid oxidation (FAO) in normal human placenta: developmental expression and activity of enzymes of mitochondria beta oxidation. Pediatr Res, 49(4), 55 (Abstract).
27. Sims HF, Brackett JC, Powell CK, Treem WR, Hale DE, Bennett MJ, Gibson B, Shapiro S & Strauss AW (1995) The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA, 92(3), 841-845.
28. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, Jackson S & Turnbull DM (1994) Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology, 19(2), 339-345. Tyni T, Ekholm E & Pihko H (1998) Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol, 178(3), 603-608.
29. Venizelos N, IJlst L, Wanders RJ & Hagenfeldt L (1994) Beta-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res, 36(1 Pt 1), 111-114.
30. Wanders RJ, IJlst L, van Gennip AH, Jakobs C, de Jager JP, Dorland L, van Sprang FJ & Duran M (1990) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis, 13(3), 311-314.
31. Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH & IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis, 22(4), 442-487.
32. Wang Y & Walsh SW (1998) Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta, 19(8), 581-586.
33. Wilcken B, Leung KC, Hammond J, Kamath R & Leonard JV (1993) Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet, 341(8842), 407-408.